Fig. 1

Kaplan-Meier curves comparing all-cause mortality between multivitamin users and non-users in No SLD and MASLD cohorts. (A) No SLD cohort before IPTW. (B) No SLD cohort after IPTW. (C) MASLD cohort before IPTW. (D) MASLD cohort after IPTW. OS, overall survival, IPTW, inverse probability of treatment weighting; SLD, steatotic liver disease; MASLD, metabolic dysfunction-associated steatotic liver disease.